Lifevantage Corporation (LFVN)

Currency in USD
5.550
+0.190(+3.54%)
Closed·
4.120-1.430(-25.77%)
·
Unusual Post-Market activity
LFVN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.2505.620
52 wk Range
5.15022.490
Key Statistics
Prev. Close
5.36
Open
5.37
Day's Range
5.25-5.62
52 wk Range
5.15-22.49
Volume
181.58K
Average Volume (3m)
198.14K
1-Year Change
-75.5937%
Book Value / Share
2.61
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LFVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
14.500
Upside
+161.26%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Lifevantage Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Lifevantage Corporation Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Employees
235

Lifevantage Corporation Earnings Call Summary for Q2/2026

  • LifeVantage reported Q2 FY2026 EPS of $0.15 (meeting expectations) while revenue fell short at $48.9M (10.83% below forecast), with stock rising 3.54% despite the miss.
  • Revenue declined 27.8% YoY with gross profit margin dropping to 74% from 80.5%, primarily attributed to decreased MindBody GLP-1 System sales amid competitive pressures.
  • The company provided FY2026 guidance of $185-$200M revenue and adjusted EPS of $0.60-$0.80, with growth expected from new product launches and the LoveBiome acquisition.
  • CEO Steve Fife emphasized strategic positioning through the LoveBiome partnership and science validation, noting that companies combining innovative products and technology will succeed.
  • Key challenges include competitive pressures in the GLP-1 market, declining margins, and the need for continuous adaptation in the evolving direct sales industry.
Last Updated: 02/05/2026, 06:34 AM
Read Full Transcript

Compare LFVN to Peers and Sector

Metrics to compare
LFVN
Peers
Sector
Relationship
P/E Ratio
6.7x20.8x12.2x
PEG Ratio
0.05−0.050.03
Price/Book
2.1x2.0x1.5x
Price / LTM Sales
0.3x1.5x0.9x
Upside (Analyst Target)
168.5%60.2%17.1%
Fair Value Upside
Unlock41.6%11.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 14.500
(+161.26% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lake Street Capital Markets
Buy12.00+116.22%30.00MaintainNov 05, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.78%
Dividend Yield
3.24%
Industry Median 2.38%
Annualized payout
0.18
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 04, 2026
EPS / Forecast
0.15 / 0.15
Revenue / Forecast
48.90M / 54.84M
EPS Revisions
Last 90 days

LFVN Income Statement

People Also Watch

86.67
CALM
+1.71%
86.45
LRN
+0.79%
7.840
CRMD
-3.45%
57.62
BMRN
+0.02%

FAQ

What Is the Lifevantage (LFVN) Stock Price Today?

The Lifevantage stock price today is 5.550

What Stock Exchange Does Lifevantage Trade On?

Lifevantage is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Lifevantage?

The stock symbol for Lifevantage is "LFVN."

Does Lifevantage Pay Dividends? What’s The Current Dividend Yield?

The Lifevantage dividend yield is 3.24%.

What Is the Lifevantage Market Cap?

As of today, Lifevantage market cap is 70.62M.

What Is Lifevantage's Earnings Per Share (TTM)?

The Lifevantage EPS (TTM) is 0.78.

When Is the Next Lifevantage Earnings Date?

Lifevantage will release its next earnings report on Apr 29, 2026.

From a Technical Analysis Perspective, Is LFVN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Lifevantage Stock Split?

Lifevantage has split 2 times.

How Many Employees Does Lifevantage Have?

Lifevantage has 235 employees.

What is the current trading status of Lifevantage (LFVN)?

As of Feb 04, 2026, Lifevantage (LFVN) is trading at a price of 5.550, with a previous close of 5.360. The stock has fluctuated within a day range of 5.250 to 5.620, while its 52-week range spans from 5.150 to 22.490.

What Is Lifevantage (LFVN) Price Target According to Analysts?

The average 12-month price target for Lifevantage is USD14.500, with a high estimate of USD17 and a low estimate of USD12. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +161.26% Upside potential.

What Is the LFVN After Hours Price?

LFVN's last after hours stock price is 4.120, the stock has decreased by -1.430, or -25.770%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.